Sage Therapeutics Inc. stock soared more than 70% Thursday to mark its biggest-ever one-day price and percentage gain, after the company reported positive results in a mid-stage trial of a treatment for severe depression that could offer doctors a new mechanism to treat the disease.
Latest posts by Market Watch (see all)
- The Wall Street Journal: China continues ‘unfair’ trade practices, says U.S. trade representative - November 20, 2018
- MarketWatch First Take: Gloomy forecasts slash tech valuations as Silicon Valley chokes on smoke - November 20, 2018
- The Wall Street Journal: Apple could provide veterans with access to electronic medical records - November 20, 2018